Gulekli B, Davies M C, Jacobs H S
Department of Reproductive Endocrinology, University College London Medical School, Middlesex Hospital, UK.
Clin Endocrinol (Oxf). 1994 Sep;41(3):275-81. doi: 10.1111/j.1365-2265.1994.tb02545.x.
Amenorrhoea in women of reproductive age causes loss of bone mineral. This study assessed the effect of treatment of amenorrhoea on bone mineral density.
Serial measurements of bone mineral density were obtained in women receiving treatment for amenorrhoea.
Eighty-five women aged 17-40 with a past or current history of amenorrhoea, from various causes, with median duration of 46.5 months (range 8 months-21 years).
Bone mineral density in the lumbar spine was measured by dual-energy X-ray absorptiometry.
Initial vertebral bone mineral density was low, mean 0.85 (SD 0.10) g/cm2. After an interval of 19.6 (SD 7.5) months on treatment there was a highly significant increase to 0.89 (SD 0.10) g/cm2 (P < 0.0005). This was equivalent to a gain in bone mass of 2.1% per year (95% confidence interval 1.5-2.8%). Improvement was seen in all diagnostic groups (except polycystic ovary syndrome) and with all types of therapy. We observed no difference in the response of previously untreated patients compared with those already on treatment, nor any change in response with increasing duration of treatment. No new fractures were reported during the study.
Bone mineral density in young women with amenorrhoea is improved by appropriate treatment, but recovery is not substantial. Hence early diagnosis and therapy is essential to prevent bone loss.
育龄期女性闭经会导致骨矿物质流失。本研究评估了闭经治疗对骨密度的影响。
对接受闭经治疗的女性进行骨密度的系列测量。
85名年龄在17至40岁之间、有既往或当前闭经病史的女性,病因各异,闭经中位持续时间为46.5个月(范围8个月至21年)。
采用双能X线吸收法测量腰椎骨密度。
初始椎体骨密度较低,平均为0.85(标准差0.10)g/cm²。治疗19.6(标准差7.5)个月后,骨密度显著升高至0.89(标准差0.10)g/cm²(P<0.0005)。这相当于每年骨量增加2.1%(95%置信区间1.5 - 2.8%)。在所有诊断组(除多囊卵巢综合征外)以及所有类型的治疗中均观察到改善。我们发现既往未治疗的患者与已接受治疗的患者在反应上没有差异,且随着治疗时间延长反应也无变化。研究期间未报告新的骨折病例。
通过适当治疗,闭经年轻女性的骨密度可得到改善,但恢复程度不大。因此,早期诊断和治疗对于预防骨质流失至关重要。